文献速递临床试验与 GCP基础与转化研究

豆奶对溃疡性结肠炎患者肠道菌群、炎症标志物及疾病严重程度影响的随机临床试验研究方案

Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2020-06-23

主要评估豆奶对肠道菌群组成、炎症生物标志物及临床症状的影响。

要点

  • 豆奶可能通过抗炎特性及蛋白质、纤维成分影响溃疡性结肠炎。
  • 研究将评估血清hs-CRP、TNF-α、IL-1β、IFN-γ及粪便钙卫蛋白、乳铁蛋白。
  • 同时分析产丁酸菌、益生菌、黏液降解菌及Firmicutes/Bacteroidetes比值。

核心结论

  • 豆奶可能有益影响溃疡性结肠炎患者的全身炎症、肠道菌群及临床症状,但尚需本试验验证。

主要发现

  • 原文未报告结果,仅描述将评估人体测量指标、血清hs-CRP、TNF-α、IL-1β、IFN-γ及粪便钙卫蛋白、乳铁蛋白。
  • 将分析粪便中产丁酸菌(Clostridium cluster IV、Faecalibacterium prausnitzii、Roseburia spp.)、益生菌(Lactobacillus spp.、Bifidobacteria spp.)、黏液降解菌(Akkermansia muciniphila、Bacteroides fragilis、Ruminococcus spp.)及Firmicutes/Bacteroidetes比值。

关键数值与推荐

  • 干预为250 mL/日豆奶联合常规治疗,持续4周。

临床怎么用

  • 目前仅为研究方案,尚无临床实践推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several strategies are recommended to alleviate clinical symptoms of ulcerative colitis (UC). Soy milk may affect UC through its anti-inflammatory properties. However, no study has examined the effects of soy milk consumption on gut microbiota and inflammatory biomarkers in patients with UC. The current study will be done to examine the effects of soy milk consumption on UC symptoms, inflammation, and gut microbiota in patients with UC. METHODS: This study is a randomized clinical trial, in which thirty patients with mild to moderate severity of UC will be randomly allocated to receive either 250 mL/day soy milk plus routine treatments (n = 15) or only routine treatments (n = 15) for 4 weeks. Assessment of anthropometric measures and biochemical indicators including serum concentrations of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interferon gamma (IFN-γ) will be done at the study baseline and end of trial. In addition, the quantity of butyrate-producing bacteria including Clostridium cluster IV, Faecalibacterium prausnitzii, and Roseburia spp.; prebiotic bacteria including Lactobacillus spp. and Bifidobacteria spp.; and mucus-degrading bacteria including Akkermansia muciniphila, Bacteroides fragilis, and Ruminococcus spp., as well as calprotectin and lactoferrin levels, will be explored in fecal samples. Also, the Firmicutes to Bacteroidetes ratio which is of significant relevance in human gut microbiota composition will be assessed. DISCUSSION: Altered gut microbiota has been reported as an important contributing factor to inflammation in patients with inflammatory bowel disease (IBD). Soy milk contains several components such as phytoestrogens with potential anti-inflammatory properties. This product might affect gut microbiota through its protein and fiber content. Therefore, soy milk might beneficially affect systemic inflammation, gut microbiota, and then clinical symptoms in patients with UC. TRIAL REGISTRATION: Iranian Registry of Clinical Trials (www.irct.ir) IRCT20181205041859N1. Registered on 27 January 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sadeghi O, Milajerdi A, Siadat SD, et al. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial. Trials. 2020. PMID: 32576228. doi:10.1186/s13063-020-04523-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。